Synvista Therapeutics, Inc.
SYNI
$0.00
$0.000.00%
| 09/30/2008 | 06/30/2008 | 03/31/2008 | 12/31/2007 | 09/30/2007 | |
|---|---|---|---|---|---|
| Net Income | 5.79% | -22.98% | 3.28% | 41.28% | 20.59% |
| Total Depreciation and Amortization | -8.57% | 12.90% | 6.90% | -12.12% | 101.29% |
| Total Amortization of Deferred Charges | -- | -- | -- | -100.00% | -59.88% |
| Total Other Non-Cash Items | -69.26% | 162.62% | 13.55% | -21.36% | 245.80% |
| Change in Net Operating Assets | 2,466.20% | 102.49% | -221.68% | 326.74% | -65.09% |
| Cash from Operations | 12.14% | 22.12% | -88.98% | 35.96% | -43.33% |
| Capital Expenditure | -146.15% | 9.30% | -19.44% | -140.00% | 21.05% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | 100.00% | -- |
| Cash from Investing | -146.15% | 9.30% | -19.44% | 99.10% | -21,031.58% |
| Total Debt Issued | -- | -- | -- | -- | -100.00% |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -100.00% | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | 100.00% | -535.29% |
| Cash from Financing | -- | -- | -- | -100.00% | 527.20% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 11.89% | 22.10% | -88.82% | -111.54% | 1,392.46% |
